✦ LIBER ✦

Preliminary results of a phase II randomized trial of docetaxel vs vinorelbine as second-line treatment in previously cisplatin-treated advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Marangolo, M; Cognetti, F; Di Costanzo, F; Selvaggi, G; Scagliotti, G.V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Combination of cisplatin, ifosfamide and

✍ Barón, FJ; Ceuva, JF; Vázquez, F; Candamio, S; Calvo, M; Menéndez, MD; Irigoyen, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Comparison of docetaxel/cisplatin to doc

✍ Georgoulias, V.; Samonis, G.; Papadakis, E.; Alexopoulos, A.; Tsiafaki, X.; Rapt 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Cisplatin-gemcitabine-vinorelbine (PGV)

✍ P. Comella; N. Panza; G.P. Nicolella; L. Manzione; V. Lorusso; R. Cioffi; G. Dec 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Docetaxel + Cisplatin (DC) and Docetaxel

✍ F. Fossella 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Temozolomide in Non—Small-Cell Lung Canc

✍ Christian S. Adonizio; James S. Babb; Christine Maiale; Chao Huang; Judy Donahue 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 135 KB